NIFTY 50 22,368.80 +0.62%SENSEX 71,593.24 -1.44%NIFTY BANK 54,799.35 +0.52%INDIA VIX 14.53 -4.86%NIFTY 100 23,396.70 +0.56%NIFTY MIDCAP 50 16,658.20 +0.77%NIFTY SMALLCAP 100 19,087.15 +0.19%IT 28,536.80 +2.89%Automobiles 24,551.40 +0.16%Metals 11,907.65 +0.32%Energy 35,638.85 -0.03%Realty 801.10 +0.56%Pharma 25,892.00 +0.27%FMCG 44,343.70 +1.02%PSU banks 8,033.05 +0.46%
NIFTY 50 22,368.80 +0.62%SENSEX 71,593.24 -1.44%NIFTY BANK 54,799.35 +0.52%INDIA VIX 14.53 -4.86%NIFTY 100 23,396.70 +0.56%NIFTY MIDCAP 50 16,658.20 +0.77%NIFTY SMALLCAP 100 19,087.15 +0.19%IT 28,536.80 +2.89%Automobiles 24,551.40 +0.16%Metals 11,907.65 +0.32%Energy 35,638.85 -0.03%Realty 801.10 +0.56%Pharma 25,892.00 +0.27%FMCG 44,343.70 +1.02%PSU banks 8,033.05 +0.46%
Finomin
/
Sign in
HHomeSCScreenerMFMFsAUGoldNWNews
Home › Stocks › Dishman Pharmaceuticals and Chemicals Ltd(Merged)
DP

Dishman Pharmaceuticals and Chemicals Ltd(Merged)

DISHMAN · NSE Healthcare
—
— today
Compare
OverviewSentimentTechnicalsFinancialsForecastsPeersHoldingsEventsNews
—
——

Sentiment

Street mood
—
No analyst coverage is collected for this company.
BuyHoldSell
Retail pulse · — votes this week
——
Community sentiment is not collected on this site.

Key metrics

Market cap
₹4,861 Cr
P/E
77.8
ROE
10.0%
Dividend yield
0.00%

Technical indicators

Daily price history is not available for this symbol, so no indicator can be computed.

Financial trend ₹ thousand Cr

RevenueNet profit
Mar 2012
Mar 2013
Mar 2014
Mar 2015
Mar 2016
TTM

Peers

CompanyPrice (₹)P/EROE1Y return
A peer set is not published for this company.

Forecasts

Consensus of — analysts covering the stock
Price target · 12M
Low —Avg —High —
Average target implies — from the current price.
Analyst ratings
Buy—
Hold—
Sell—

Fair-value sandbox

FREE — usually behind a paywall
Tweak the assumptions; the target updates instantly. Your model, not our advice.
Revenue growth · next 5Y10% /yr
Operating margin15%
Exit P/E · year 578×
Discount rate
Implied fair value
₹—
— vs current —
Your assumptions, your arithmetic — not a valuation or a recommendation.
Simple 5-year earnings model on FY26 EPS of —. Assumptions are yours — not a recommendation.

Mutual funds invested

Top funds holding the stock, by share of market cap held
Fund · top 5Market-cap held
HDFC Flexi Cap Fund
GROWTH
0.1632%
ICICI Pru Bluechip Fund
GROWTH
0.1607%
SBI Equity Hybrid Fund
GROWTH
0.0748%
Nippon India Large Cap
GROWTH
0.0744%
UTI Nifty 50 Index Fund
GROWTH
0.0547%
Compare 3-month MF holding change on the screenerGo to screener ›

Health check ALL CHECKS FREE

Five checks across value, growth and risk
Return on equity
10.0%
›
Price to earnings
77.8
›
Dividend yield
0.00%
›

Shareholding pattern

Promoters61.4%
Foreign institutions10.92%
Domestic institutions9.92%
Public17.76%

Insider & bulk deals

Insider and bulk-deal filings are not collected on this site.
Deals above ₹10 Cr reported in the last 90 days.

In the news

About

Dishman Pharmaceuticals and Chemicals Limited operates as an outsourcing partner for the pharmaceutical industry. The Company manufactures and supplies intermediates, fine chemicals and various products for pharmaceutical, cosmetic and related industries.

Founded—
Headquarters—
IndustryPharmaceuticals